What is Sleepiz?
Founded in 2018, Sleepiz specializes in patient-centric disease management through its proprietary contactless monitoring technology. The company's flagship device, designed for bedside placement, utilizes sophisticated algorithms to track heart contractions, respiratory patterns, and body movements without requiring physical contact with the user. This innovation addresses a critical need for continuous, longitudinal health data that is often inaccessible in traditional clinical settings. By transforming the bedside table into a diagnostic hub, Sleepiz provides healthcare providers with actionable insights, thereby facilitating earlier interventions and more personalized treatment plans for chronic conditions related to sleep and cardiovascular health.
How much funding has Sleepiz raised?
Sleepiz has raised a total of $4.8M across 1 funding round:
Series A
$4.8M
Series A (2021): $4.8M with participation from ZKB and Verve Ventures
Key Investors in Sleepiz
ZKB
Zürcher Kantonalbank is a major Swiss financial institution that provides venture capital and growth financing to support the development of innovative regional startups.
Verve Ventures
Verve Ventures is an early-stage venture fund focused on identifying and investing in innovative companies within sectors like Healthcare, Mobility, and Deep Tech, particularly emphasizing Artificial Intelligence and Machine Learning.
What's next for Sleepiz?
With this major enterprise-level funding, Sleepiz is well-positioned to accelerate its commercial expansion and deepen its research and development efforts. The strategic capital will likely be deployed to scale manufacturing capabilities, enhance the underlying machine learning models for improved diagnostic precision, and navigate the complex regulatory landscapes required for broader international market entry. As the healthcare industry continues to shift toward decentralized, home-based care models, Sleepiz is poised to play a pivotal role in defining the future of remote patient monitoring. The company's trajectory suggests a focus on establishing strategic partnerships with healthcare systems and insurance providers to integrate its technology into standard care pathways, ultimately driving long-term value for stakeholders and improving patient outcomes on a global scale.
See full Sleepiz company page
